Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUC-MSC PLEB001 in steroid-refractory acute gastrointestinal GVHD (Phase III, single-arm)
CTR20223467Phase 3Completed
- Sponsor
- Bosen Biotech
- Start
- Feb 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of amimestrocel in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Bosen Biotech. Started Feb 2023; status: completed.
02
Drugs
amimestrocel
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on CTR20223467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20223467.